Brawn Biotech informs about quarterly statement on investor complaints

07 Jan 2017 Evaluate

Brawn Biotech has informed about Quarterly Statement on Investor Complaints / Grievances Redressal Mechanism for the Quarter ended December 31, 2016, under Regulation 13(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

The above information is a part of company’s filings submitted to BSE.

Brawn Biotech Share Price

20.85 0.00 (0.00%)
27-Mar-2026 16:59 View Price Chart
Peers
Company Name CMP
Redington 199.45
Adani Enterprises 1759.65
Amrapali Industries 13.75
Rashi Peripheral 339.60
PDS 260.80
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×